Abstract:<p class="a-plus-plus">Vitiligo is an autoimmune disease of the skin characterized by epidermal melanocyte loss resulting in white patches, with an approximate prevalence of 0.5–2% worldwide. Several precipitating factors by chemical exposure and skin injury present commonly in patients with vitiligo. Although the diagnosis appears to be straightforward for the distinct clinical phenotype and specific histological features, vitiligo provides many challenges including chronicity, treatment resistance, frequent relapse, associated profound psychosocial effect, and negative impact on quality of life. Multiple mechanisms are involved in melanocyte disappearance, including genetics, environmental factors, and immune-mediated inflammation. Compelling evidence supports the melanocyte intrinsic abnormalities with poor adaptation to stressors leading to instability and release of danger signals, which will activate dendritic cells, natural killer cells, and innate lymphoid cells to initiate innate immunity, ultimately resulting in T-cell mediated adaptive immune response and melanocyte destruction. Importantly, the cross- talk between keratinocytes, melanocytes, and immune cells, such as interferon (IFN)-γ signaling pathway, builds inflammatory loops that give rise to the disease deterioration. Improved understanding of the immune pathogenesis of vitiligo has led to the development of new therapeutic options including Janus kinase (JAK) inhibitors targeting IFN-γ signaling pathways, which can effectively reverse depigmentation. Furthermore, definition of treatment goals and integration of comorbid diseases into vitiligo management have revolutionized the way vitiligo is treated. In this review, we highlight recent developments in vitiligo clinical aspects and immune pathogenesis. Our key objective is to raise awareness of the complexity of this disease, the potential of prospective therapy strategies, and the need for early and comprehensive management.</p>

Effect of invigorating spleen benefiting liver and kidney treating children's vitiligo at stable period

The Treatment of Vitiligo with Liver and Kidney Deficiencies

Advances in the Function of Traditional Medicine for Vitiligo Treatment

Analysis of Clinical Characteristics and Theraputic of Children Vitiligo

Effect on CD4~+/CD8~+T Lymphocyte Ratio and CD4~+CD25~+ Treg of Three Treatments to Patients with Sporadic Vitiligo

Detection and Analysis of Immune-Related Indexs in 90 Children with Vitiligo Vulgaris

Clinical analysis of childhood vitiligo prognosis assessment

Clinical observation on treating vitiligo based on the collateral disease theory

Observation on the Effect of Compound Traditional Chinese Medicine with Narrow-band Ultraviolet B in the Treatment of Vitiligo

Childhood Vitiligo in China

Clinical characteristics and therapeutic efficacy analysis on 10 000 cases of vitiligo

Clinical Features, Immunopathogenesis, and Therapeutic Strategies in Vitiligo

Ideas and Methods in Prevention and Treatment of Chronic Liver Disease with TCM Liver and Spleen Related Theory

Research on Effect of Nourishing Yin, Replenishing Qi and Detoxicating on Systemic Lupus Erythematosus

Observation on Clinical Efficacy of Shengxueling in Treatment of 53 Cases of Hormone Refractory Immune Thrombocytopenia

The influence of invigorating kidney and spleen on the curative effect of the chronic hepatitis B carriers

Pediatric Patients with Vitiligo in Eastern China: Abnormalities in 145 Cases Based on Thyroid Function Tests and Immunological Findings

Clinical Features and Therapy of 73 Cases of Congenital Vitiligo

Detection and Significance of CD4+CD25+ Foxp3+ Regulatory T Cells in the Peripheral Blood of Patients with Vitiligo

Abnormality of Parameters of Thyroid Function and Incidence of Autoimmune Diseases in Children with Vitiligo

Systematic Understanding the Mechanisms of Vitiligo Pathogenesis and Its Treatment by Qubaibabuqi Formula.